Lower Respiratory Tract Infection — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for lower respiratory tract infection. 28 active patents protecting 3 drugs from 3+ originators. First major cliff: 2026. Daily refresh.

3
Approved drugs
28
Active US patents
52/100
Avg vulnerability
—
Annual revenue covered

Originators in Lower Respiratory Tract Infection

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Beecham/GSK) 14 patents Baxter 9 patents ANI Pharmaceuticals 5 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating lower respiratory tract infection. Each bar = one year. Y-axis scaled to peak year (6 patents).

2
26
1
27
3
28
4
30
4
32
6
34
5
35
2
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Amoxil
amoxicillin
 Generic (originally Beecham/GSK) 14 58 — 2026-12-08
Metro I.V. In Plastic Container
METRONIDAZOLE
 Baxter 9 58 — 2028-02-02
Vancocin
vancomycin
 ANI Pharmaceuticals 5 39 — 2035-11-06

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8299052 Amoxil method of use 85 2027-05-07
8778924 Amoxil method of use 80 2026-12-08
8658678 Metro I.V. In Plastic Container method of use 75 2028-06-27
11931463 Amoxil method of use 75 2034-02-12
12257236 Metro I.V. In Plastic Container method of use 75 2039-01-16
11878011 Amoxil method of use 75 2042-05-27
8357394 Amoxil formulation 65 2026-12-08
8946276 Metro I.V. In Plastic Container method of use 62 2032-06-28
9198858 Metro I.V. In Plastic Container method of use 62 2032-06-28
9050263 Amoxil method of use 62 2034-02-12

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7977488 Amoxil composition of matter 18 2030-04-10
7977488 Amoxil composition of matter 18 2030-04-10
10849956 Vancocin formulation 25 2035-11-06
11000567 Vancocin formulation 25 2035-11-06
10238606 Amoxil formulation 42 2034-02-12
10596155 Metro I.V. In Plastic Container formulation 42 2032-06-28
10238634 Metro I.V. In Plastic Container formulation 42 2032-06-28
10039804 Vancocin method of use 45 2035-11-06
10188697 Vancocin method of use 45 2035-11-06
11541035 Metro I.V. In Plastic Container formulation 50 2039-10-04

Related